Elevated IgE levels are linked to faster relapse in omalizumab-discontinued chronic spontaneous urticaria patients
Publication date: Available online 1 September 2017 Source:Journal of Allergy and Clinical Immunology Author(s): Ragip Ertas, Kemal Ozyurt, Emin Ozlu, Yilmaz Ulas, Atil Avci, Mustafa Atasoy, Tomasz Hawro, Marcus Maure
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου